These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32182224)

  • 1. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
    El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
    J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norrin mediates opposing effects on tumor progression of glioblastoma stem cells.
    Kassumeh S; Priglinger SG; Ohlmann A
    J Clin Invest; 2020 Jun; 130(6):2814-2815. PubMed ID: 32391807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.
    Zhang K; Harada Y; Wei X; Shukla D; Rajendran A; Tawansy K; Bedell M; Lim S; Shaw PX; He X; Yang Z
    J Biol Chem; 2011 Mar; 286(12):10210-5. PubMed ID: 21177847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells.
    Rajakulendran N; Rowland KJ; Selvadurai HJ; Ahmadi M; Park NI; Naumenko S; Dolma S; Ward RJ; So M; Lee L; MacLeod G; Pasiliao C; Brandon C; Clarke ID; Cusimano MD; Bernstein M; Batada N; Angers S; Dirks PB
    Genes Dev; 2019 May; 33(9-10):498-510. PubMed ID: 30842215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norrin maintains malignancy of gastric cancer cells in part through activating AKT signaling.
    Liu L; Qin ZY; Liu Q; Wen LZ; Liu KW; Guo Y; Zhou YB; Wang B; Chen DF; Wang T
    Biochem Biophys Res Commun; 2019 Apr; 512(2):405-411. PubMed ID: 30902385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical and functional characterization of Norrin signaling through Frizzled4.
    Bang I; Kim HR; Beaven AH; Kim J; Ko SB; Lee GR; Kan W; Lee H; Im W; Seok C; Chung KY; Choi HJ
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):8787-8792. PubMed ID: 30104375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells.
    Seitz R; Hackl S; Seibuchner T; Tamm ER; Ohlmann A
    J Neurosci; 2010 Apr; 30(17):5998-6010. PubMed ID: 20427659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
    Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
    Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
    Tompa M; Kalovits F; Nagy A; Kalman B
    Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt activation promotes neuronal differentiation of glioblastoma.
    Rampazzo E; Persano L; Pistollato F; Moro E; Frasson C; Porazzi P; Della Puppa A; Bresolin S; Battilana G; Indraccolo S; Te Kronnie G; Argenton F; Tiso N; Basso G
    Cell Death Dis; 2013 Feb; 4(2):e500. PubMed ID: 23429286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive overexpression of Norrin activates Wnt/β-catenin and endothelin-2 signaling to protect photoreceptors from light damage.
    Braunger BM; Ohlmann A; Koch M; Tanimoto N; Volz C; Yang Y; Bösl MR; Cvekl A; Jägle H; Seeliger MW; Tamm ER
    Neurobiol Dis; 2013 Feb; 50():1-12. PubMed ID: 23009755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
    Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
    Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
    Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
    Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
    Jin J; Grigore F; Chen CC; Li M
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.